Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Eculizumab Is Safe and Effective as a Long-term Treatment for Protein-losing Enteropathy Due to CD55 Deficiency.

Kurolap A, Eshach Adiv O, Hershkovitz T, Tabib A, Karbian N, Paperna T, Mory A, Vachyan A, Slijper N, Steinberg R, Zohar Y, Mevorach D, Baris Feldman H.

J Pediatr Gastroenterol Nutr. 2018 Nov 8. doi: 10.1097/MPG.0000000000002198. [Epub ahead of print]

PMID:
30418410
2.

Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.

Tabib A, Hindi I, Karbian N, Zelig O, Falach B, Mevorach D.

Thromb Res. 2018 Aug;168:67-77. doi: 10.1016/j.thromres.2018.06.006. Epub 2018 Jun 11.

PMID:
29929138
3.

Demyelination, strokes, and eculizumab: Lessons from the congenital CD59 gene mutations.

Tabib A, Karbian N, Mevorach D.

Mol Immunol. 2017 Sep;89:69-72. doi: 10.1016/j.molimm.2017.05.024. Epub 2017 Jun 13. Review.

PMID:
28622911
4.

Mechanisms of defense against products of cysteine catabolism in the nematode Caenorhabditis elegans.

Livshits L, Chatterjee AK, Karbian N, Abergel R, Abergel Z, Gross E.

Free Radic Biol Med. 2017 Mar;104:346-359. doi: 10.1016/j.freeradbiomed.2017.02.007. Epub 2017 Feb 4.

PMID:
28179109

Supplemental Content

Loading ...
Support Center